Schedule 13G ownership disclosure

REDHILL BIOPHARMA LTD

American Depositary Shares · CUSIP: 757468301

Event date: 2025-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • YA II PN, Ltd.

    Shares: 508,723.00 · Class: 9.9%

  • YA Global Investments II (U.S.), LP

    Shares: 508,723.00 · Class: 9.9%

  • Yorkville Advisors Global, LP

    Shares: 508,723.00 · Class: 9.9%

  • Yorkville Advisors Global II, LLC

    Shares: 508,723.00 · Class: 9.9%

  • YAII GP, LP

    Shares: 508,723.00 · Class: 9.9%

  • YAII GP II, LLC

    Shares: 508,723.00 · Class: 9.9%

  • Mark Angelo

    Shares: 508,723.00 · Class: 9.9%

  • SC-Sigma Global Partners, LP

    Shares: 508,723.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-124194
Form type
SCHEDULE 13G
Filer
RedHill Biopharma Ltd.
CIK
CIK 1553846
Filed
Dec 23, 2025
Reporting period
Dec 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub